1. Home
  2. SRPT vs NAKAW Comparison

SRPT vs NAKAW Comparison

Compare SRPT & NAKAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • NAKAW
  • Stock Information
  • Founded
  • SRPT 1980
  • NAKAW N/A
  • Country
  • SRPT United States
  • NAKAW United States
  • Employees
  • SRPT N/A
  • NAKAW 61
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • NAKAW
  • Sector
  • SRPT Health Care
  • NAKAW
  • Exchange
  • SRPT Nasdaq
  • NAKAW Nasdaq
  • Market Cap
  • SRPT N/A
  • NAKAW N/A
  • IPO Year
  • SRPT 1997
  • NAKAW 2024
  • Fundamental
  • Price
  • SRPT $20.28
  • NAKAW $8.01
  • Analyst Decision
  • SRPT Buy
  • NAKAW
  • Analyst Count
  • SRPT 26
  • NAKAW 0
  • Target Price
  • SRPT $70.92
  • NAKAW N/A
  • AVG Volume (30 Days)
  • SRPT 6.5M
  • NAKAW N/A
  • Earning Date
  • SRPT 08-06-2025
  • NAKAW N/A
  • Dividend Yield
  • SRPT N/A
  • NAKAW N/A
  • EPS Growth
  • SRPT N/A
  • NAKAW N/A
  • EPS
  • SRPT N/A
  • NAKAW N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • NAKAW N/A
  • Revenue This Year
  • SRPT $26.87
  • NAKAW N/A
  • Revenue Next Year
  • SRPT $3.15
  • NAKAW N/A
  • P/E Ratio
  • SRPT N/A
  • NAKAW N/A
  • Revenue Growth
  • SRPT 59.15
  • NAKAW N/A
  • 52 Week Low
  • SRPT $18.30
  • NAKAW N/A
  • 52 Week High
  • SRPT $173.25
  • NAKAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 20.82
  • NAKAW N/A
  • Support Level
  • SRPT $18.30
  • NAKAW N/A
  • Resistance Level
  • SRPT $22.98
  • NAKAW N/A
  • Average True Range (ATR)
  • SRPT 2.20
  • NAKAW 0.00
  • MACD
  • SRPT -1.46
  • NAKAW 0.00
  • Stochastic Oscillator
  • SRPT 8.90
  • NAKAW 0.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About NAKAW Kindly MD Inc. Warrants

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: